Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
25.7M
-
Number of holders
-
45
-
Total shares
-
8.73M
-
Shares change
-
+1.67M
-
Total reported value, excl. options
-
$70.9M
-
Value change
-
+$13.6M
-
Number of buys
-
34
-
Number of sells
-
-7
-
Price
-
$8.13
Significant Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q4 2020
43 filings reported holding ETON - Eton Pharmaceuticals, Inc. - Common Stock as of Q4 2020.
Eton Pharmaceuticals, Inc. - Common Stock (ETON) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.73M shares
of 25.7M outstanding shares and own 33.91% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (4.04M shares), BlackRock Inc. (1.05M shares), AWM Investment Company, Inc. (972K shares), VANGUARD GROUP INC (867K shares), STATE STREET CORP (244K shares), GEODE CAPITAL MANAGEMENT, LLC (216K shares), NORTHERN TRUST CORP (184K shares), MML INVESTORS SERVICES, LLC (129K shares), TWO SIGMA INVESTMENTS, LP (126K shares), and Westside Investment Management, Inc. (83.9K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.